Personality factors as predictors of programme completion of drug therapeutic communities

Lynne MAGOR-BLATCH, Navjot Bhullar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Using the Millon Clinical Multiaxial Inventory ¿ III (MCMI-III), this study examined what personality factors, if any, would predict retention within therapeutic community (TC) treatment for residents presenting with amphetamine-type stimulant (ATS) use disorders. The study utilised a prospective, cohort design. Participants were 213 residents (130 males) from 12 TCs in Australia, with ages ranging from 19 to 58 years. The MCMI-III was administered at the commencement of the study and follow-up discharge information was obtained from TCs at 12 months post-baseline to determine which residents had completed the treatment programme and the reason for discharge. The study revealed a high prevalence of personality and psychopathology symptomatology within an ATS-using population with scores in the clinical range (>84) on a number of personality factors. Those most likely to have left treatment prematurely or been discharged scored higher on Antisocial, Narcissistic, Negativistic, Sadistic, Schizoid, Schizotypal, Alcohol Dependence, Drug Dependence, Dysthymia, and Major Depression scales. However, no significant personality differences were observed between programme completers and non-completers. While a follow-up measure of personality was not taken, results of this study suggest personality functioning may be improved during treatment. This raises possibilities for TCs and other treatment services in relation to the inclusion of specific treatment interventions within the TC. It is recommended that future research examine the extent to which ATS users' personality pathology changes during TC-based treatment, to provide a further insight into suitable evidence-based treatment approaches specific to an ATS-using population.
Original languageEnglish
Pages (from-to)110-124
Number of pages15
JournalMental Health and Substance Use
Volume7
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Therapeutic Community
Personality
Amphetamine
Pharmaceutical Preparations
Millon Clinical Multiaxial Inventory
Psychopathology
Population
Alcoholism
Substance-Related Disorders
Depression
Pathology

Cite this

MAGOR-BLATCH, Lynne ; Bhullar, Navjot. / Personality factors as predictors of programme completion of drug therapeutic communities. In: Mental Health and Substance Use. 2014 ; Vol. 7, No. 2. pp. 110-124.
@article{67af0754194d458da010691523485bc2,
title = "Personality factors as predictors of programme completion of drug therapeutic communities",
abstract = "Using the Millon Clinical Multiaxial Inventory ¿ III (MCMI-III), this study examined what personality factors, if any, would predict retention within therapeutic community (TC) treatment for residents presenting with amphetamine-type stimulant (ATS) use disorders. The study utilised a prospective, cohort design. Participants were 213 residents (130 males) from 12 TCs in Australia, with ages ranging from 19 to 58 years. The MCMI-III was administered at the commencement of the study and follow-up discharge information was obtained from TCs at 12 months post-baseline to determine which residents had completed the treatment programme and the reason for discharge. The study revealed a high prevalence of personality and psychopathology symptomatology within an ATS-using population with scores in the clinical range (>84) on a number of personality factors. Those most likely to have left treatment prematurely or been discharged scored higher on Antisocial, Narcissistic, Negativistic, Sadistic, Schizoid, Schizotypal, Alcohol Dependence, Drug Dependence, Dysthymia, and Major Depression scales. However, no significant personality differences were observed between programme completers and non-completers. While a follow-up measure of personality was not taken, results of this study suggest personality functioning may be improved during treatment. This raises possibilities for TCs and other treatment services in relation to the inclusion of specific treatment interventions within the TC. It is recommended that future research examine the extent to which ATS users' personality pathology changes during TC-based treatment, to provide a further insight into suitable evidence-based treatment approaches specific to an ATS-using population.",
keywords = "comorbidity, mental health, outcome predictors, residential treatment, substance dependence, treatment outcome",
author = "Lynne MAGOR-BLATCH and Navjot Bhullar",
year = "2014",
doi = "10.1080/17523281.2013.806345",
language = "English",
volume = "7",
pages = "110--124",
journal = "Mental Health and Substance Use: Dual Diagnosis",
issn = "1752-3273",
publisher = "Routledge",
number = "2",

}

Personality factors as predictors of programme completion of drug therapeutic communities. / MAGOR-BLATCH, Lynne; Bhullar, Navjot.

In: Mental Health and Substance Use, Vol. 7, No. 2, 2014, p. 110-124.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Personality factors as predictors of programme completion of drug therapeutic communities

AU - MAGOR-BLATCH, Lynne

AU - Bhullar, Navjot

PY - 2014

Y1 - 2014

N2 - Using the Millon Clinical Multiaxial Inventory ¿ III (MCMI-III), this study examined what personality factors, if any, would predict retention within therapeutic community (TC) treatment for residents presenting with amphetamine-type stimulant (ATS) use disorders. The study utilised a prospective, cohort design. Participants were 213 residents (130 males) from 12 TCs in Australia, with ages ranging from 19 to 58 years. The MCMI-III was administered at the commencement of the study and follow-up discharge information was obtained from TCs at 12 months post-baseline to determine which residents had completed the treatment programme and the reason for discharge. The study revealed a high prevalence of personality and psychopathology symptomatology within an ATS-using population with scores in the clinical range (>84) on a number of personality factors. Those most likely to have left treatment prematurely or been discharged scored higher on Antisocial, Narcissistic, Negativistic, Sadistic, Schizoid, Schizotypal, Alcohol Dependence, Drug Dependence, Dysthymia, and Major Depression scales. However, no significant personality differences were observed between programme completers and non-completers. While a follow-up measure of personality was not taken, results of this study suggest personality functioning may be improved during treatment. This raises possibilities for TCs and other treatment services in relation to the inclusion of specific treatment interventions within the TC. It is recommended that future research examine the extent to which ATS users' personality pathology changes during TC-based treatment, to provide a further insight into suitable evidence-based treatment approaches specific to an ATS-using population.

AB - Using the Millon Clinical Multiaxial Inventory ¿ III (MCMI-III), this study examined what personality factors, if any, would predict retention within therapeutic community (TC) treatment for residents presenting with amphetamine-type stimulant (ATS) use disorders. The study utilised a prospective, cohort design. Participants were 213 residents (130 males) from 12 TCs in Australia, with ages ranging from 19 to 58 years. The MCMI-III was administered at the commencement of the study and follow-up discharge information was obtained from TCs at 12 months post-baseline to determine which residents had completed the treatment programme and the reason for discharge. The study revealed a high prevalence of personality and psychopathology symptomatology within an ATS-using population with scores in the clinical range (>84) on a number of personality factors. Those most likely to have left treatment prematurely or been discharged scored higher on Antisocial, Narcissistic, Negativistic, Sadistic, Schizoid, Schizotypal, Alcohol Dependence, Drug Dependence, Dysthymia, and Major Depression scales. However, no significant personality differences were observed between programme completers and non-completers. While a follow-up measure of personality was not taken, results of this study suggest personality functioning may be improved during treatment. This raises possibilities for TCs and other treatment services in relation to the inclusion of specific treatment interventions within the TC. It is recommended that future research examine the extent to which ATS users' personality pathology changes during TC-based treatment, to provide a further insight into suitable evidence-based treatment approaches specific to an ATS-using population.

KW - comorbidity

KW - mental health

KW - outcome predictors

KW - residential treatment

KW - substance dependence

KW - treatment outcome

U2 - 10.1080/17523281.2013.806345

DO - 10.1080/17523281.2013.806345

M3 - Article

VL - 7

SP - 110

EP - 124

JO - Mental Health and Substance Use: Dual Diagnosis

JF - Mental Health and Substance Use: Dual Diagnosis

SN - 1752-3273

IS - 2

ER -